SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC 1993 Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366: 575580.
  • 2
    Blum JW, Fischer JA, Hunziker WH, Binswanger U, Picotti GB, Da Prada M, Guillebeau A 1978 Parathyroid hormone responses to catecholamines and to changes of extracellular calcium in cows. J Clin Invest 61: 11131122.
  • 3
    Yamamoto M, Igarashi T, Muramatsu M, Fukagawa M, Motokura T, Ogata E 1989 Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat. J Clin Invest 83: 10531056.
  • 4
    Naveh-Many T, Friedlaender MM, Mayer H, Silver J 1989 Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D. Endocrinology 125: 275280.
  • 5
    Sela-Brown A, Silver J, Brewer G, Naveh-Many T 2000 Identification of AUF1 as a parathyroid hormone mRNA 3′-untranslated region-binding protein that determines parathyroid hormone mRNA stability. J Biol Chem 275: 74247429.
  • 6
    Stauffer M, Baylink D, Wergedal J, Rich C 1973 Decreased bone formation, mineralization, and enhanced resorption in calcium-deficient rats. Am J Physiol 225: 269276.
  • 7
    Chan AS 1976 Effect of a low calcium diet on the ultrastructure of the parathyroid gland of chicks. Cell Tissue Res 173: 7176.
  • 8
    Wernerson A, Widholm SM, Svensson O, Reinholt FP 1991 Parathyroid cell number and size in hypocalcemic young rats. Acta Pathol Microbiol Immunol Scand 99: 10961102.
  • 9
    Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG 1993 Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 12971303.
  • 10
    Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM 1994 Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93: 11081112.
  • 11
    Stumpf WE, Sar M, Reid FA, Huang S, Narbaitz R, DeLuca HF 1981 Autoradiographic studies with 3H 1,25 (OH)2 vitamin D2 and 3H 25 (OH) vitamin D3 in rat parathyroid glands. Cell Tissue Res 221: 333338.
  • 12
    Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, Möller G, Adamski J, Balling R 2002 Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 16: 15241537.
  • 13
    Russell J, Lettieri D, Sherwood LM 1986 Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology 119: 28642866.
  • 14
    Nygren P, Larsson R, Johansson H, Ljunghall S, Rastad J, Akerstrom G 1988 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tissue Int 43: 213218.
  • 15
    Szabo A, Merke J, Beier E, Mall G, Ritz E 1989 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 35: 10491056.
  • 16
    Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S 1997 Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16: 391396.
  • 17
    Li YC, Pirro AE, Amling M, Delling G, Baroni R, Bronson R, Demay MB 1997 Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94: 98319835.
  • 18
    Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB 1998 Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139: 43914396.
  • 19
    Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG 2003 Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17: 509511.
  • 20
    Fukagawa M 1999 Cell biology of parathyroid hyperplasia in uremia. Am J Med Sci 317: 377382.
  • 21
    Brandi L, Daugaard H, Tvedegaard E, Storm T, Olgaard K 1989 Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis. Nephron 53: 194200.
  • 22
    Brown AJ, Dusso AS, Slatopolsky E 2002 Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant 17(Suppl 10): 1019.
  • 23
    Wada M, Nagano N, Furuya Y, Chin J, Nemeth EF, Fox J 2000 Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism. Kidney Int 57: 5058.
  • 24
    Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG 2004 Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 15161525.
  • 25
    Dolbeare F 1996 Bromodeoxyuridine: A diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization. Histochem J 28: 531575.
  • 26
    Luts L, Sundler F 1998 Autotransplantation of rat parathyroid glands: A study on morphological changes. Transplantation 66: 446453.
  • 27
    Erben RG 1997 Embedding of bone samples in methylmethacrylate: An improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45: 307313.
  • 28
    Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB 1999 Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140: 49824987.
  • 29
    Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D 2004 Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279: 1675416766.
  • 30
    Canaff L, Hendy GN 2002 Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 277: 3033730350.
  • 31
    Wang Q, Palnitkar S, Parfitt AM 1997 The basal rate of cell proliferation in normal human parathyroid tissue: Implications for the pathogenesis of hyperparathyroidism. Clin Endocrinol (Oxf) 46: 343349.
  • 32
    Li YC, Pirro AE, Demay MB 1998 Analysis of vitamin D-dependent calcium-binding protein messenger ribonucleic acid expression in mice lacking the vitamin D receptor. Endocrinology 139: 847851.
  • 33
    Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G 2001 Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects. Proc Natl Acad Sci USA 98: 1332413329.
  • 34
    Hesse M, Frohlich LF, Zeitz U, Lanske B, Erben RG 2007 Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol 26: 7584.
  • 35
    Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP 2002 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229238.
  • 36
    Kotchen TA, Guthrie GP Jr 1988 Effects of calcium on renin and aldosterone. Am J Cardiol 62: 41G46G.
  • 37
    Petrov V, Lijnen P 1999 Modification of intracellular calcium and plasma renin by dietary calcium in men. Am J Hypertens 12: 12171224.
  • 38
    Wang W, Li C, Kwon TH, Miller RT, Knepper MA, Frokiaer J, Nielsen S 2004 Reduced expression of renal Na+ transporters in rats with PTH-induced hypercalcemia. Am J Physiol Renal Physiol 286: F534F545.
  • 39
    el Hajj FG, Seifter J, Scott J, Brown EM 1998 Calcium-regulated renal calcium handling in healthy men: Relationship to sodium handling. J Clin Endocrinol Metab 83: 23662372.
  • 40
    Kifor O, Moore FD Jr, Wang P, Goldstein M, Vassilev P, Kifor I, Hebert SC, Brown EM 1996 Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81: 15981606.
  • 41
    Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E, Drueke TB 1997 Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51: 328336.
  • 42
    Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K 2002 Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation. J Am Soc Nephrol 13: 21102116.
  • 43
    Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T 2004 Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 15: 25792587.
  • 44
    Wang Q, Paloyan E, Parfitt AM 1996 Phosphate administration increases both size and number of parathyroid cells in adult rats. Calcif Tissue Int 58: 4044.
  • 45
    Naveh-Many T, Rahamimov R, Livni N, Silver J 1995 Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium, phosphate, and vitamin D. J Clin Invest 96: 17861793.
  • 46
    Wang Q, Palnitkar S, Parfitt AM 1996 Parathyroid cell proliferation in the rat: Effect of age and of phosphate administration and recovery. Endocrinology 137: 45584562.
  • 47
    Lewin E, Wang W, Olgaard K 1997 Reversibility of experimental secondary hyperparathyroidism. Kidney Int 52: 12321241.